| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.
|
Clin Infect Dis
|
2006
|
13.01
|
|
2
|
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
|
Ann Intern Med
|
2003
|
3.96
|
|
3
|
Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.
|
Clin Infect Dis
|
2005
|
3.04
|
|
4
|
Antiscience and ethical concerns associated with advocacy of Lyme disease.
|
Lancet Infect Dis
|
2011
|
2.88
|
|
5
|
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.
|
J Infect Dis
|
2008
|
2.26
|
|
6
|
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans.
|
Am J Trop Med Hyg
|
2008
|
1.82
|
|
7
|
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis.
|
J Antimicrob Chemother
|
2010
|
1.75
|
|
8
|
Long-term follow-up of patients with culture-confirmed Lyme disease.
|
Am J Med
|
2003
|
1.62
|
|
9
|
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
|
Diagn Microbiol Infect Dis
|
2012
|
1.45
|
|
10
|
Single-dose prophylaxis against Lyme disease.
|
Lancet Infect Dis
|
2007
|
1.45
|
|
11
|
Brief communication: hematogenous dissemination in early Lyme disease.
|
Ann Intern Med
|
2005
|
1.24
|
|
12
|
Babesiosis in Lower Hudson Valley, New York, USA.
|
Emerg Infect Dis
|
2011
|
1.24
|
|
13
|
Erythema migrans.
|
Infect Dis Clin North Am
|
2008
|
1.14
|
|
14
|
Microbiologic evaluation of patients from Missouri with erythema migrans.
|
Clin Infect Dis
|
2005
|
1.10
|
|
15
|
Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.
|
Clin Vaccine Immunol
|
2008
|
1.08
|
|
16
|
The amber theory of Lyme arthritis: initial description and clinical implications.
|
Clin Rheumatol
|
2012
|
0.97
|
|
17
|
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States.
|
Clin Infect Dis
|
2009
|
0.94
|
|
18
|
Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii.
|
Vector Borne Zoonotic Dis
|
2011
|
0.92
|
|
19
|
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States.
|
MMWR Recomm Rep
|
2016
|
0.90
|
|
20
|
Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease.
|
Arthritis Rheumatol
|
2014
|
0.89
|
|
21
|
Recognition and treatment of erythema migrans: are we off target?
|
Ann Intern Med
|
2002
|
0.88
|
|
22
|
Response to meta-analysis of Lyme borreliosis symptoms.
|
Int J Epidemiol
|
2005
|
0.87
|
|
23
|
Human granulocytic anaplasmosis during pregnancy: case series and literature review.
|
Clin Infect Dis
|
2007
|
0.86
|
|
24
|
Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.
|
J Clin Microbiol
|
2013
|
0.82
|
|
25
|
Lyme disease and the heart.
|
Front Biosci
|
2003
|
0.82
|
|
26
|
Evidence for strain-specific immunity in patients treated for early lyme disease.
|
Infect Immun
|
2014
|
0.82
|
|
27
|
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.
|
J Med Ethics
|
2010
|
0.81
|
|
28
|
Novel influenza A (H1N1) in patients with hematologic malignancies.
|
J Clin Oncol
|
2009
|
0.77
|
|
29
|
Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit.
|
Infect Control Hosp Epidemiol
|
2011
|
0.76
|
|
30
|
Reinfection versus relapse in Lyme disease.
|
N Engl J Med
|
2013
|
0.75
|
|
31
|
Duration of treatment for Lyme borreliosis: time for a critical reappraisal.
|
Wien Klin Wochenschr
|
2002
|
0.75
|
|
32
|
Relationship between population density of attorneys and prevalence of methicillin-resistant Staphylococcus aureus: is medical-legal pressure on physicians a driving force behind the development of antibiotic resistance?
|
Am J Ther
|
2009
|
0.75
|